Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Hemangioendothelioma, Epithelioid × Methotrexate × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 76 Leukemia 58 Lymphoma 44 Leukemia, Myeloid, Acute 31 Burkitt Lymphoma 31 Myelodysplastic Syndromes 25 Lymphoma, Non-Hodgkin 23 Lymphoma, Mantle-Cell 23 Hodgkin Disease 23 Lymphoma, Large B-Cell, Diffuse 20 Leukemia, Lymphocytic, Chronic, B-Cell 20 Lymphoma, Follicular 18 Recurrence 17 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 17 Graft vs Host Disease 17 Lymphoma, B-Cell, Marginal Zone 13 Congenital Abnormalities 13 Multiple Myeloma 12 Leukemia, Myelomonocytic, Chronic 12 Lymphoma, Large-Cell, Immunoblastic 11 Leukemia, Myeloid, Chronic-Phase 11 Leukemia, Myeloid, Accelerated Phase 11 Breast Neoplasms 11 Myeloproliferative Disorders 10 Lymphoma, Large-Cell, Anaplastic 10 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 10 Hematologic Neoplasms 10 Blast Crisis 10 Primary Myelofibrosis 9 Osteosarcoma 9

Interventions

tremelimumab 1 trametinib 1 pazopanib 1 eribulin 1 durvalumab 1 HhAntag691 1 Gemcitabine 1 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡